Canadian Commercial-Stage Biopharmaceutical Company Theratechnologies Announces NASDAQ Listing 

NEXT STORY
Slovakia Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests 2019: Supplier Shares and Strategies, Volume and Sales Segment Forecasts
PREV STORY
Emergent BioSolutions Receives EMA Prime Designation for Its Chikungunya Virus VLP Vaccine Candidate
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Synairgen announces inclusion of its inhaled interferon beta treatment in US NIH ACTIV-2 trial in COVID-19 outpatients

author_avatar
NASDAQ Market News

The American Health Council Board of Nurses Welcomes Sarah Kavalauskas MSN, BSN, RN, PALS, ACLS, NRCME

NEW YORK, July 27, 2018 (GLOBE NEWSWIRE) -- The American Health Council is proud ...

author_avatar
NASDAQ Market News

Revelation Biosciences Inc. Receives Approval to Initiate Phase 2b Viral Challenge Study of REVTx 99, an Experimental Prophylactic Treatment for the Prevention of Respiratory Viral Infections

author_avatar
NASDAQ Market News